TY  - GEN
AU  - Mittelman,Moshe
AU  - Oster,Howard S
AU  - Hoffman,Michael
AU  - Neumann,Drorit
TI  - The lower risk MDS patient at risk of rapid progression
SN  - 1873-5835
PY  - 2010///1221
KW  - Age Factors
KW  - Antigens, Differentiation
KW  - blood
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Caspase 3
KW  - biosynthesis
KW  - Chromosome Aberrations
KW  - Cyclin-Dependent Kinase Inhibitor p15
KW  - Cytokines
KW  - DNA Methylation
KW  - genetics
KW  - Erythrocyte Transfusion
KW  - Female
KW  - Ferritins
KW  - Fibrosis
KW  - Gene Expression Regulation
KW  - Humans
KW  - Immunosuppression Therapy
KW  - Immunosuppressive Agents
KW  - Inhibitor of Apoptosis Proteins
KW  - Lenalidomide
KW  - Leukocyte Count
KW  - Lipoproteins, LDL
KW  - Lymphoid Enhancer-Binding Factor 1
KW  - Male
KW  - Microtubule-Associated Proteins
KW  - Mutation
KW  - Myelodysplastic Syndromes
KW  - diagnosis
KW  - Platelet Count
KW  - Prognosis
KW  - Proto-Oncogene Proteins
KW  - Proto-Oncogene Proteins c-bcl-2
KW  - Receptor Protein-Tyrosine Kinases
KW  - Risk Factors
KW  - Sex Factors
KW  - Survivin
KW  - Thalidomide
KW  - analogs & derivatives
KW  - alpha Catenin
KW  - Axl Receptor Tyrosine Kinase
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1016/j.leukres.2010.05.023
ER  -